Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy
Our analysis of a large, real-world cohort of patients undergoing TAVR showed that patients with HOCM have a significantly higher risk of in-hospital mortality and procedural complications when compared to patients without HOCM.
Authors
- Jafar A. Alzubi (ORCID: https://orcid.org/0000-0001-6724-1421)
- Muhammad Usman Almani (ORCID: https://orcid.org/0000-0002-7848-432X)
- Muhammad Yousuf (ORCID: https://orcid.org/0000-0003-0545-1890)
- Vibhor Ahluwalia
- Christian Witzke (ORCID: https://orcid.org/0000-0003-0886-9395)
- Raphael Bonita (ORCID: https://orcid.org/0000-0001-5784-4798)
- Mohammad Hamza (ORCID: https://orcid.org/0000-0002-6237-0221)
Institutions
- Yale New Haven Hospital (US)
- Mayo Clinic (US)
- Thomas Jefferson University Hospital (US)
- Nazareth Hospital (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- SUNY Cortland (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1002/ccd.70201
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78